WGU D116 Advanced Pharmacology
Study Guide Questions Well Detailed
Answers Plus Rationales 2026 Q&A
Instant Download Pdf
1. Which pharmacokinetic process describes movement of a drug
from the site of administration into systemic circulation?
A. Distribution
B. Absorption
C. Metabolism
D. Excretion
Answer: B. Absorption
Rationale: Absorption is the movement of a drug from its administration
site into the bloodstream.
2. Which organ is primarily responsible for hepatic drug
metabolism?
A. Kidney
B. Heart
C. Liver
D. Pancreas
Answer: C. Liver
Rationale: The liver contains many enzymes, particularly cytochrome
P450 enzymes, responsible for phase I drug metabolism.
3. A drug with a high first-pass effect generally has what
characteristic?
A. Increased oral bioavailability
, B. Reduced oral bioavailability
C. Increased renal clearance
D. Complete absorption
Answer: B. Reduced oral bioavailability
Rationale: Extensive metabolism in the intestinal wall and liver before
systemic circulation reduces the amount of active drug reaching the
bloodstream.
4. Which pharmacokinetic parameter describes the amount of drug
required to produce a particular plasma concentration?
A. Clearance
B. Half-life
C. Volume of distribution
D. Loading dose
Answer: C. Volume of distribution
Rationale: Volume of distribution reflects the apparent volume in which
a drug distributes relative to its plasma concentration.
5. A medication has a half-life of 8 hours. Approximately how long
will it take to reach near steady state with repeated dosing?
A. 4 hours
B. 8 hours
C. 16 hours
D. 32–40 hours
Answer: D. 32–40 hours
Rationale: Most drugs reach approximately 90–97% steady state after
about 4–5 half-lives.
6. Which drug characteristic generally increases distribution into
tissues?
A. High water solubility only
, B. High lipid solubility
C. Strong plasma protein binding
D. Large molecular size
Answer: B. High lipid solubility
Rationale: Lipid-soluble medications readily cross cell membranes and
may distribute extensively into tissues.
7. Which laboratory value is especially important when evaluating
renal drug clearance?
A. ALT
B. Hemoglobin
C. Serum creatinine
D. Bilirubin
Answer: C. Serum creatinine
Rationale: Serum creatinine contributes to assessment of kidney
function and helps guide dosing for renally eliminated medications.
8. Which pharmacodynamic concept describes the maximum effect
a drug can produce?
A. Potency
B. Efficacy
C. Affinity
D. Bioavailability
Answer: B. Efficacy
Rationale: Efficacy refers to the maximal therapeutic effect achievable
with a drug.
9. A drug requiring a smaller dose to achieve a specified effect is
considered more:
A. Efficacious
B. Potent
, C. Toxic
D. Bioavailable
Answer: B. Potent
Rationale: Potency refers to the amount of drug needed to produce a
particular effect.
10. What type of antagonist binds to the same receptor as an
agonist and competes for receptor occupancy?
A. Competitive antagonist
B. Noncompetitive antagonist
C. Partial agonist
D. Inverse agonist
Answer: A. Competitive antagonist
Rationale: Competitive antagonists compete with agonists for the same
receptor binding site.
11. Which medication is a selective serotonin reuptake inhibitor
(SSRI)?
A. Fluoxetine
B. Haloperidol
C. Lithium
D. Alprazolam
Answer: A. Fluoxetine
Rationale: Fluoxetine is an SSRI that increases serotonergic activity by
inhibiting serotonin reuptake.
12. A patient taking an SSRI develops agitation, diaphoresis,
hyperreflexia, and clonus. Which condition is most concerning?
A. Neuroleptic malignant syndrome
B. Serotonin syndrome
Study Guide Questions Well Detailed
Answers Plus Rationales 2026 Q&A
Instant Download Pdf
1. Which pharmacokinetic process describes movement of a drug
from the site of administration into systemic circulation?
A. Distribution
B. Absorption
C. Metabolism
D. Excretion
Answer: B. Absorption
Rationale: Absorption is the movement of a drug from its administration
site into the bloodstream.
2. Which organ is primarily responsible for hepatic drug
metabolism?
A. Kidney
B. Heart
C. Liver
D. Pancreas
Answer: C. Liver
Rationale: The liver contains many enzymes, particularly cytochrome
P450 enzymes, responsible for phase I drug metabolism.
3. A drug with a high first-pass effect generally has what
characteristic?
A. Increased oral bioavailability
, B. Reduced oral bioavailability
C. Increased renal clearance
D. Complete absorption
Answer: B. Reduced oral bioavailability
Rationale: Extensive metabolism in the intestinal wall and liver before
systemic circulation reduces the amount of active drug reaching the
bloodstream.
4. Which pharmacokinetic parameter describes the amount of drug
required to produce a particular plasma concentration?
A. Clearance
B. Half-life
C. Volume of distribution
D. Loading dose
Answer: C. Volume of distribution
Rationale: Volume of distribution reflects the apparent volume in which
a drug distributes relative to its plasma concentration.
5. A medication has a half-life of 8 hours. Approximately how long
will it take to reach near steady state with repeated dosing?
A. 4 hours
B. 8 hours
C. 16 hours
D. 32–40 hours
Answer: D. 32–40 hours
Rationale: Most drugs reach approximately 90–97% steady state after
about 4–5 half-lives.
6. Which drug characteristic generally increases distribution into
tissues?
A. High water solubility only
, B. High lipid solubility
C. Strong plasma protein binding
D. Large molecular size
Answer: B. High lipid solubility
Rationale: Lipid-soluble medications readily cross cell membranes and
may distribute extensively into tissues.
7. Which laboratory value is especially important when evaluating
renal drug clearance?
A. ALT
B. Hemoglobin
C. Serum creatinine
D. Bilirubin
Answer: C. Serum creatinine
Rationale: Serum creatinine contributes to assessment of kidney
function and helps guide dosing for renally eliminated medications.
8. Which pharmacodynamic concept describes the maximum effect
a drug can produce?
A. Potency
B. Efficacy
C. Affinity
D. Bioavailability
Answer: B. Efficacy
Rationale: Efficacy refers to the maximal therapeutic effect achievable
with a drug.
9. A drug requiring a smaller dose to achieve a specified effect is
considered more:
A. Efficacious
B. Potent
, C. Toxic
D. Bioavailable
Answer: B. Potent
Rationale: Potency refers to the amount of drug needed to produce a
particular effect.
10. What type of antagonist binds to the same receptor as an
agonist and competes for receptor occupancy?
A. Competitive antagonist
B. Noncompetitive antagonist
C. Partial agonist
D. Inverse agonist
Answer: A. Competitive antagonist
Rationale: Competitive antagonists compete with agonists for the same
receptor binding site.
11. Which medication is a selective serotonin reuptake inhibitor
(SSRI)?
A. Fluoxetine
B. Haloperidol
C. Lithium
D. Alprazolam
Answer: A. Fluoxetine
Rationale: Fluoxetine is an SSRI that increases serotonergic activity by
inhibiting serotonin reuptake.
12. A patient taking an SSRI develops agitation, diaphoresis,
hyperreflexia, and clonus. Which condition is most concerning?
A. Neuroleptic malignant syndrome
B. Serotonin syndrome
